Division of Urology, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
Int J Urol. 2024 Oct;31(10):1153-1158. doi: 10.1111/iju.15534. Epub 2024 Jul 15.
Surgical resection for pheochromocytoma (PCC) is still challenging. This study assessed the perioperative outcomes of adrenalectomy for PCC and investigated the risk factors for intraoperative hemodynamic instability (HI).
This retrospective study included 571 patients with adrenal tumors who underwent adrenalectomy at Kobe University Hospital and other related hospitals between April 2008 and October 2023. The perioperative outcomes of laparoscopic adrenalectomy were compared between PCC (n = 92) and non-PCC (n = 464) groups. In addition, we investigated several potential risk factors for intraoperative HI in patients with PCC (n = 107; open, n = 11; laparoscopic, n = 92; robot-assisted, n = 4).
While patients with PCC had a significantly larger amount of blood loss in comparison to those with non-PCC (mean, 70 and 30 mL, respectively; p = 0.004), no significant difference was observed in the rate of perioperative grade ≥III complications (1.1% vs. 0.6%; p = 0.516), and no perioperative mortality was observed in either group. A tumor size of ≥40 mm, with preoperative hypertension and urinary metanephrines at a level ≥3 times the upper limit of the normal value, were found to be significant predictors of HI, with odds ratios of 2.74 (p = 0.025), 3.91 (p = 0.005), and 3.83 (p = 0.004), respectively.
Our data suggest that laparoscopic adrenalectomy for PCC may be as safe as that for other types of adrenal tumors and that large tumors and hormonally active disease may be risk factors for intraoperative HI. The optimal perioperative management for PCC with these risk factors should be established.
对于嗜铬细胞瘤(PCC)的外科切除仍然具有挑战性。本研究评估了肾上腺切除术治疗 PCC 的围手术期结果,并探讨了术中血流动力学不稳定(HI)的危险因素。
本回顾性研究纳入了 2008 年 4 月至 2023 年 10 月期间在神户大学医院和其他相关医院接受肾上腺切除术的 571 例肾上腺肿瘤患者。比较了 PCC(n=92)和非 PCC(n=464)组的腹腔镜肾上腺切除术围手术期结果。此外,我们还研究了 PCC 患者(n=107;开放手术,n=11;腹腔镜手术,n=92;机器人辅助手术,n=4)术中 HI 的几个潜在危险因素。
与非 PCC 患者相比,PCC 患者的出血量明显更多(分别为 70 和 30 mL;p=0.004),但围手术期≥III 级并发症的发生率无显著差异(1.1%比 0.6%;p=0.516),两组均无围手术期死亡。肿瘤大小≥40 mm、术前高血压和尿间甲肾上腺素水平≥正常值的 3 倍被发现是 HI 的显著预测因素,优势比分别为 2.74(p=0.025)、3.91(p=0.005)和 3.83(p=0.004)。
我们的数据表明,腹腔镜肾上腺切除术治疗 PCC 可能与治疗其他类型的肾上腺肿瘤一样安全,并且大肿瘤和激素活性疾病可能是术中 HI 的危险因素。对于具有这些危险因素的 PCC,应建立最佳的围手术期管理。